Identification and quantification of phytochemicals of Chamaecostus cuspidatus (Nees & Mart.) CDSpecht & DWStev and Cheilocostus speciosus (J. Koenig) CDSpecht by LC-MS techniques and their in-vitro anti-adipogenic screening

Chamaecostus cuspidatus (Nees & Mart.) C.D.Specht & D.W.Stev and Cheilocostus speciosus (J.Koenig) C.D.Specht contain bioactive compounds that possess many pharmacological activities including antidiabetic and hypolipidemic. These plants are used to treat diabetes by herbal healers. Considering the traditional use of C. cuspidatus and C. speciosus, the present study is designed to perform qualitative and quantitative analysis as well as in-vitro anti-adipogenesis against 3T3-L1 cells to ensure efficacy. A total of thirty-eight compounds were identified using HPLC-QTOF-MS/MS. Quantification of ten bioactive compounds among identified compounds was performed by UPLC-QqQ(LIT)-MS/MS. The quantification method was validated according to ICH guidelines (International conference on harmonization guidelines). Quantification of bioactive compounds of different organs of C. cuspidatus and C. speciosus showed remarkable differences in the content. Microscopic and ORO absorbance confirmed the antiadipogenic potential of leaves (L-02), roots (R-02) of C. cuspidatus and leaves of C. speciosus (L-01) in 3T3-L1 cells.

Automated summary

This study confirmed the traditional use of Chamaecostus cuspidatus and Cheilocostus speciosus in treating diabetes and reducing lipid levels through qualitative and quantitative analysis as well as in-vitro experiments. The content of bioactive compounds varied significantly among different organs. The anti-adipogenic potential of specific parts of these plants was also observed.